HomeTechLeadershipVentureFortune InsidersMost Powerful WomenAutomotiveCareersEnergy & EnvironmentExecutive TravelFinanceHealthinternationalRetailMarketsMagazineNewslettersVideosFortune Conferences

SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Brand Index Methodology

The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.

Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.

Roberto Machado — Noa LightRocket via Getty Images

135

Abbott Laboratories

ABT
 

The pharmaceutical company manufactures medical devices, medications that help treat HIV, Crohn’s disease, arthritis, psoriasis, and many others, as well as supplements and nutritional products like Ensure.

Looking for leads, investment insights, or competitive intelligence?

GET PREMIUM ACCESS

CEO

Miles D. White

CEO Title

Chairman & Chief Executive Officer

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Abbott Park, IL

Website

www.abbott.com

Years on Fortune 500 List

23

Employees

75,000

Acquired St. Jude Medical (2016 rank: 434), Jan. 4, 2017.Profile provided by S&P Global.
Abbott Laboratories is also featured in these fortune lists

World’s Most Admired Companies

Abbott Laboratories: Fortune 500 RANK HISTORY
 
 
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$20,8530.9%
Profits ($M)$1,400.0-68.3%
Assets ($M)$52,666
Total Stockholder Equity ($M)$20,538
Market Value — as of March 31, 2017 ($M)$76,740
Profit Ratios
Profit as % of Revenues6.7%
Profits as % of Assets2.7%
Profits as % of Stockholder Equity6.8%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)0.94
EPS % Change (from 2015)-67.8%
EPS % Change (5 year annual rate)-20.8%
EPS % Change (10 year annual rate)-1.7%
Total Return
Total Return to Investors (2016)-12.2%
Total Return to Investors (5 year, annualized)9.9%
Total Return to Investors (10 year, annualized)8.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Abbott Laboratories

FDA Approves First-Ever Blood Sugar Monitor That Doesn't Require a Fingerstick

Abbott's blood sugar monitor takes the pain and hassle out of checking glucose levels.

Read More →
465,000 Pacemakers Recalled on Hacking Fears

Here's how to protect your heart.

Read More →
Siemens Plans to Boost Security on Medical Scanners

As is, some of the equipment could be hacked.

Read More →
Abbott Finally Agrees to Buy Alere After Cutting the Price to $4.5 Billion

The firms have been fighting about the merger since it was announced in February 2016.

Read More →
Ryan Lochte Becomes PowerBar Pitchman

Energy bar is giving controversial swimmer a clean start.

Read More →
134
136
Customer ServiceSite MapPrivacy PolicyFeedbackAd ChoicesAdvertisingYour California Privacy RightsReprints & PermissionsTerms of UseCareers
All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc.. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
© 2017 Time Inc. All rights reserved. Fortune.com is a part of the Time.com network of sites.